CDKN2D
関連文献

“Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.”. Mol. Cell. Biol. 15 (5):  2672–81. (1995). doi:10.1128/MCB.15.5.2672. PMC 230497. PMID 7739547. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC230497/.
“Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4.”. Mol. Cell. Biol. 15 (5):  2682–8. (1995). doi:10.1128/MCB.15.5.2682. PMC 230498. PMID 7739548. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC230498/.
“Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4.”. Mol. Biol. Cell 7 (1):  57–70. (1996). doi:10.1091/mbc.7.1.57. PMC 278612. PMID 8741839. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC278612/.
“Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells.”. Leukemia 11 (1):  54–63. (1997). doi:10.1038/sj.leu.2400522. PMID 9001419.
“Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a.”. Nature 395 (6699):  237–43. (1998). doi:10.1038/26155. PMID 9751050.
“Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d.”. Nature 395 (6699):  244–50. (1998). doi:10.1038/26164. PMID 9751051.
“Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a.”. Structure 6 (10):  1279–90. (1998). doi:10.1016/S0969-2126(98)00128-2. PMID 9782052.
“Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.”. Oncogene 18 (9):  1663–76. (1999). doi:10.1038/sj.onc.1202466. PMID 10208428.
“Mutation testing in melanoma families: INK4A, CDK4 and INK4D.”. Br. J. Cancer 80 (1–2):  295–300. (1999). doi:10.1038/sj.bjc.6690354. PMC 2363010. PMID 10390011. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363010/.
“Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases.”. Proc. Natl. Acad. Sci. U.S.A. 96 (23):  13462–7. (1999). doi:10.1073/pnas.96.23.13462. PMC 23970. PMID 10557343. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC23970/.
“Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors.”. FEBS Lett. 470 (2):  161–6. (2000). doi:10.1016/S0014-5793(00)01307-7. PMID 10734227.
“Lack of p19INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis.”. Oncogene 19 (36):  4146–50. (2000). doi:10.1038/sj.onc.1203769. PMID 10962575.
“Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors.”. Exp. Hematol. 29 (4):  490–8. (2001). doi:10.1016/S0301-472X(01)00619-1. PMID 11301189.
“Protein folding and stability of human CDK inhibitor p19(INK4d).”. J. Mol. Biol. 315 (3):  447–57. (2002). doi:10.1006/jmbi.2001.5242. PMID 11786024.
“Molecular cloning and characterization of the human p19(INK4d) gene promoter.”. FEBS Lett. 517 (1–3):  272–6. (2002). doi:10.1016/S0014-5793(02)02647-9. PMID 12062451.
“Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors.”. Genes Chromosomes Cancer 35 (2):  176–81. (2002). doi:10.1002/gcc.10108. PMID 12203782.
“Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.”. Proc. Natl. Acad. Sci. U.S.A. 99 (26):  16899–903. (2003). doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC139241/.
“Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.”. Nat. Biotechnol. 21 (5):  566–9. (2004). doi:10.1038/nbt810. PMID 12665801.
“Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells.”. Br. J. Cancer 88 (8):  1277–80. (2004). doi:10.1038/sj.bjc.6600862. PMC 2747579. PMID 12698196. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747579/.